Crossref
journal-article
Elsevier BV
Neurobiology of Disease (78)
References
39
Referenced
103
10.1126/science.281.5381.1322
/ Science / The Bcl-2 protein family: arbiters of cell survival by Adams (1998)10.1038/sj.cdd.4400733
/ Cell Death Differ. / Caspase 6 activity initiates caspase 3 activation in cerebellar granule cell apoptosis by Allsopp (2000)10.1073/pnas.222550499
/ Proc. Natl. Acad. Sci. U. S. A. / Antiepileptic drugs and apoptotic neurodegeneration in the developing brain by Bittigau (2002)10.1083/jcb.200302109
/ J. Cell Biol. / Alternating metabolic pathways in NGF-deprived sympathetic neurons affect caspase-independent death by Chang (2003)10.1016/0006-8993(71)90130-2
/ Brain Res. / An improved cupric-silver method for impregnation of axonal and terminal degeneration by DeOlmos (1971)10.1006/nbdi.2001.0411
/ Neurobiol. Dis. / Apoptosis in the in vivo mammalian forebrain by Dikranian (2001)10.1002/(SICI)1097-4547(20000101)59:1<24::AID-JNR4>3.0.CO;2-8
/ J. Neurosci. Res. / Caspase-3 is required for apoptosis-associated DNA fragmentation but not for cell death in neurons deprived of potassium by D'Mello (2000)10.1016/S0092-8674(00)00008-8
/ Cell / Smac, a mitochondria protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition by Du (2000)10.1097/00004647-199803000-00002
/ J. Cereb. Blood Flow Metab. / Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family by Endres (1998)10.1016/S0166-2236(00)01601-5
/ Trends Neurosci. / Neuronal apoptosis versus programmed cell death by Fujikawa (2000)10.1074/jbc.M202931200
/ J. Biol. Chem. / Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury by Han (2002)10.1073/pnas.94.5.2007
/ Proc. Natl. Acad. Sci. U.S.A. / Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage by Hara (1997)10.1523/JNEUROSCI.3356-04.2004
/ J. Neurosci. / Caspase-7 expanded function and intrinsic expression level underlies strain-specific brain phenotype of caspase-3 null mice by Houde (2004)10.1126/science.287.5455.1056
/ Science / Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome by Ikonomidou (2000)10.1523/JNEUROSCI.23-03-00876.2003
/ J. Neurosci. / Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits by Jevtovic-Todorovic (2003)10.1038/bjc.1972.33
/ Br. J. Cancer / Apoptosis: a basic biological phenomenon with wideranging implications in tissue kinetics by Kerr (1972)10.1038/384368a0
/ Nature / Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice by Kuida (1996)10.1073/pnas.232473399
/ Proc. Natl. Acad. Sci. / Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation by Le (2002)10.1093/jnen/61.8.673
/ J. Neuropathol. Exp. Neurol. / Strain-dependent neurodevelopmental abnormalities in caspase-3-deficient mice by Leonard (2002)10.1038/35083620
/ Nature / Endonuclease G is an apoptotic DNase when released from mitochondria by Li (2001)10.1083/jcb.139.1.205
/ J. Cell Biol. / Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death by Miller (1997)10.1038/sj.cdd.4400442
/ Cell Death Differ. / Investigation of glucocorticoid-induced apoptotic pathway: processing of caspase-6 but not caspase-3 by Miyashita (1998)10.1016/S1471489202000024
/ Curr. Opin. Pharmacol. / Excitotoxicity, apoptosis and neuropsychiatric disorders by Olney (2003)10.1006/nbdi.2001.0475
/ Neurobiol. Dis. / Ethanol-induced caspase-3 activation in the in vivo developing mouse brain by Olney (2002)10.1016/S0165-3806(02)00279-1
/ Brain Res. Dev. Brain Res. / Ethanol-induced apoptotic neurodegeneration in the developing C57BL/6 mouse brain by Olney (2002)10.1016/j.tips.2004.01.002
/ Trends Pharmacol. Sci. / Do pediatric drugs cause developing neurons to commit suicide? by Olney (2004)10.1523/JNEUROSCI.21-13-04752.2001
/ J. Neurosci. / Programmed cell death of developing mammalian neurons after genetic deletion of caspases by Oppenheim (2001)10.1093/jnen/60.9.829
/ J. Neuropathol. Exp. Neurol. / Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion by Roth (2001)10.1002/mrdd.1036
/ Ment. Retard. Dev. Disabil. Res. Rev. / Apoptosis and brain development by Roth (2001)10.1016/S0166-2236(99)01435-6
/ Trends Neurosci. / Neuronal apoptosis in acute necrotic insults: why is this subject such a mess? by Roy (1999)10.1093/emboj/21.8.1967
/ EMBO / Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation by Ruchaud (2002)10.1074/jbc.M008363200
/ J. Biol. Chem. / Executioner caspase-3, -6, and-7 perform distinct, non-redundant roles during the demolition phase of apoptosis by Slee (2001)10.1016/S0165-6147(00)01867-8
/ Trends Pharmacol. Sci. / Apoptosis: a guide for the perplexed by Sloviter (2002)10.1074/jbc.271.43.27099
/ J. Biol. Chem. / The Ced-3/Interleukin 1β converting enzyme-like homolog Mch6 and the Lamin-cleaving enzyme Mch2α are substrates for the apoptotic mediator CPP32 by Srinivasula (1996)10.1523/JNEUROSCI.19-15-06235.1999
/ J. Neurosci. / Caspase-dependent and -independent death of camptothecin-treated embryonic cortical neurons by Stefanis (1999)10.1038/17135
/ Nature / Molecular characterization of mitochondrial apoptosis-inducing factor by Susin (1999)10.1016/S0092-8674(00)00009-X
/ Cell / Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins by Verhagen (2000)10.1016/S0074-7696(08)62312-8
/ Int. Rev. Cytol. / Cell death: the significance of apoptosis by Wyllie (1980)10.1038/sj.cdd.4401277
/ Cell Death Differ. / Ethanol-induced neuronal apoptosis in vivo requires BAX in the developing mouse brain by Young (2003)
Dates
Type | When |
---|---|
Created | 20 years, 3 months ago (June 1, 2005, 6:26 a.m.) |
Deposited | 1 day, 11 hours ago (Sept. 3, 2025, 6:48 p.m.) |
Indexed | 1 day, 9 hours ago (Sept. 3, 2025, 8:40 p.m.) |
Issued | 19 years, 10 months ago (Nov. 1, 2005) |
Published | 19 years, 10 months ago (Nov. 1, 2005) |
Published Print | 19 years, 10 months ago (Nov. 1, 2005) |
Funders
2
National Alliance for Research on Schizophrenia and Depression
10.13039/100009670
Region: Americas
pri (Trusts, charities, foundations (both public and private))
Labels
1
- NARSAD
National Institutes of Health
10.13039/100000002
Region: Americas
gov (National government)
Labels
3
- Institutos Nacionales de la Salud
- US National Institutes of Health
- NIH
Awards
4
- AG 11355
- HD 37100
- NS35107
- DA 05072
@article{Young_2005, title={Role of caspase-3 in ethanol-induced developmental neurodegeneration}, volume={20}, ISSN={0969-9961}, url={http://dx.doi.org/10.1016/j.nbd.2005.04.014}, DOI={10.1016/j.nbd.2005.04.014}, number={2}, journal={Neurobiology of Disease}, publisher={Elsevier BV}, author={Young, Chainllie and Roth, Kevin A. and Klocke, Barbara J. and West, Tim and Holtzman, David M. and Labruyere, Joann and Qin, Yue-Qin and Dikranian, Krikor and Olney, John W.}, year={2005}, month=nov, pages={608–614} }